State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

Low testosterone levels may increase the risk of higher-grade “extreme” progression of prostate cancer among men enrolled in active surveillance (AS), according to a study published online Feb 24 in ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Phase 3 study of 68Ga-PSMA-11 PET combined with MRI for the detection of prostate cancer (BIPASS). Background: Biochemical recurrence (BCR) affects 20–50% of men within 10 years of primary therapy for ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

What if a simple conversation could save your life? For thousands of men each year, talking openly about prostate cancer and taking action makes all the difference. Prostate cancer is the most common ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

When is the last time the men in your life had a real talk about their health? Seeing as September is Prostate Cancer Awareness Month, it’s a good time to start the conversation. Prostate cancer cases ...

EAU26: prostate cancer screening compares favourably compared to breast cancer in identifying significant cancers and reducing mortality.

But does it cost too much?

But as it turned out, his transition from military service to civilian life came with prostate cancer. It was during his ...